Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05991167 · ClinicalTrials.gov registry record
EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")
A clinical trial of ADHD, sponsored by Akili Interactive Labs.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05991167: Active study of ADHD, sponsored by Akili Interactive Labs.
NCT05991167 is a study of ADHD that is active but no longer recruiting, run by Akili Interactive Labs. The registered enrollment target is 150 participants, below the 188-participant average among 75 other ADHD trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05991167, a study of ADHD, is active but no longer recruiting, sponsored by Akili Interactive Labs.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.
Conditions Studied
Interventions
- DEVICE EndeavorRx
Study Locations (1)
Massachusetts
- Akili Interactive Labs, Inc. - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT05991167 still lists
NCT05991167 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 188-participant average among 75 other ADHD trials with a reported enrollment target (20% lower).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which EndeavorRx is the first listed.
NCT05991167 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05991167 about?
NCT05991167 is a clinical study titled "EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")". The EndeavorRx Prospective Product Registry aims to collect real world data from participants receiving the digital therapeutic, EndeavorRx, under conditions of routine clinical practice.
What is the current status of trial NCT05991167?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-06-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05991167 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT05991167?
The interventions under investigation include: EndeavorRx (DEVICE).
Who is sponsoring clinical trial NCT05991167?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05991167 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05991167's enrollment target sits among peer trials
150 25th of 75 higher than 51 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI